2 protocol(s) meet the specified criteria
Drug: Avelumab
Protocol No.TitleStatus
DF-HCC17101-PACE DF-HCC 17-101: Palbociclib After CDK and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer (Protocol #: 17-101)Open
GI17-319A Single Arm, Multi-center Phase 2 Trial of mFOLFOX6 + Trastuzumab + Avelumab in First-line, Metastatic, HER2-amplified Gastric and Esophageal AdenocarcinomasOpen